Skip to main content
Earnings Labs
Evotec SE logo

Evotec SE (EVO)

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic

$1.95

+0.26%

Mkt Cap $1.08B

Analyst Ratings

No recent rating data.

Price Target (4 analysts)

$7.00

Range $7.00$7.00

Implied Upside

+259.9%

Consensus $7.00 vs current $1.95